Cases 61 - 70 of 915
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv01228
Plaintiff:
Bayer Pharma AG and Bayer AG
Counter Defendant:
Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Counter Claimant:
Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
OVERTON v. MYLAN LABORATORIES LTD. et al
as 1:2022cv05859
Plaintiff:
JOANNE OVERTON
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
County Of Westchester et al v. Actavis Holdco US, Inc. et al
as 2:2021cv04474
Plaintiff:
County Of Westchester, Illinois Public Risk Fund and United Crafts Benefits Fund
Defendant:
ACTAVIS HOLDCO U.S. INC., ACTAVIS ELIZABETH LLC, ACTAVIS PHARMA, INC. and others
Cause Of Action: 15 U.S.C. § 15 Antitrust Litigation
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv01040
Counter Defendant:
Novo Nordisk Inc.
Plaintiff:
Novo Nordisk A/S
Defendant:
Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
TRAUTMAN v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05471
Plaintiff:
Yvonne Trautman
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
RODRIGUEZ et al v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05040
Plaintiff:
ESTEBAN C RODRIGUEZ, ESTEBAN C. RODRIGUEZ and DIANA R. BALAY
Defendant:
AUROBINDO PHARMA LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DIZINNO v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv05325
Plaintiff:
DORIS DIZINNO
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
ANDREOTTI et al v. MYLAN LABORATORIES, LTD. et al
as 1:2022cv05291
Plaintiff:
DAVID ANDREOTTI and LAURIE ANDREOTTI
Defendant:
MYLAN LABORATORIES, LTD., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CASTILLO v. MYLAN LABORATORIES LTD. et al
as 1:2022cv05097
Plaintiff:
Jose Castillo
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHAMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CARTER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv04800
Plaintiff:
TIERRA CARTER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
